Cargando…

Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes

We conducted a discovery genome-wide association study with expression quantitative trait loci (eQTL) annotation of new-onset diabetes (NOD) among European Americans, who were exposed to a calcium channel blocker-based strategy (CCB strategy) or a β-blocker-based strategy (β-blocker strategy) in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Shin-Wen, McDonough, Caitrin W., Gong, Yan, Johnson, Todd A., Tsunoda, Tatsuhiko, Gamazon, Eric R., Perera, Minoli A., Takahashi, Atsushi, Tanaka, Toshihiro, Kubo, Michiaki, Pepine, Carl J., Johnson, Julie A., Cooper-DeHoff, Rhonda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368017/ https://www.ncbi.nlm.nih.gov/pubmed/27670767 http://dx.doi.org/10.1038/tpj.2016.67

Ejemplares similares

Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials
por: Magvanjav, Oyunbileg, et al.
Publicado: (2017)

Optimizing Antihypertensive Medication Classification in Electronic Health Record-Based Data: Classification System Development and Methodological Comparison
por: McDonough, Caitrin W, et al.
Publicado: (2020)

Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study
por: McDonough, Caitrin W., et al.
Publicado: (2013)

Genome‐Wide Meta‐Analysis of Blood Pressure Response to β(1)‐Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies)
por: Singh, Sonal, et al.
Publicado: (2019)

2246: Characterization of resistant hypertension in a statewide electronic health record-based database (OneFlorida)
por: McDonough, Caitrin W., et al.
Publicado: (2018)

Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy
por: Gerhard, Tobias, et al.
Publicado: (2012)

Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients
por: Mehanna, Mai, et al.
Publicado: (2022)

Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort
por: Karnes, Jason H, et al.
Publicado: (2013)

Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients
por: Mehanna, Mai, et al.
Publicado: (2021)

Hypertension in Florida: Data From the OneFlorida Clinical Data Research Network
por: Smith, Steven M., et al.
Publicado: (2018)

Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response
por: Singh, Sonal, et al.
Publicado: (2019)

Pharmacogenomics of Hypertension: A Genome‐Wide, Placebo‐Controlled Cross‐Over Study, Using Four Classes of Antihypertensive Drugs
por: Hiltunen, Timo P., et al.
Publicado: (2015)

Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta‐Blockers in European Americans
por: Singh, Sonal, et al.
Publicado: (2019)

Large‐Scale Gene‐Centric Analysis Identifies Polymorphisms for Resistant Hypertension
por: Fontana, Vanessa, et al.
Publicado: (2014)

Antihypertensive Drug Class Interactions and Risk for Incident Diabetes: A Nested Case–Control Study
por: Cooper‐DeHoff, Rhonda M., et al.
Publicado: (2013)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
por: Smith, Steven M., et al.
Publicado: (2022)

Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response
por: Turner, Stephen T, et al.
Publicado: (2012)

2235: Equipping health professional students to apply pharmacogenomic data to clinical decision making in real-world scenarios: Comparison of an active engagement Versus didactic teaching approach
por: Arwood, Meghan J., et al.
Publicado: (2018)

Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics
por: Sá, Ana Caroline C., et al.
Publicado: (2017)

Personalized antihypertensive treatment guided by pharmacogenomics in China
por: Xiao, Zhi-Lin, et al.
Publicado: (2022)

Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma
por: Dahlin, Amber, et al.
Publicado: (2015)

Simple Integer Risk Score to Determine Prognosis of Patients With Hypertension and Chronic Stable Coronary Artery Disease
por: Bavry, Anthony A., et al.
Publicado: (2013)

Systolic blood pressure, heart rate, and outcomes in patients with coronary disease and heart failure
por: Elgendy, Islam Y., et al.
Publicado: (2019)

Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance Program
por: Grande, Kendra J., et al.
Publicado: (2022)

Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies
por: Sá, Ana Caroline C., et al.
Publicado: (2018)

Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial
por: Dasa, Osama, et al.
Publicado: (2021)

Translating pharmacogenomics discoveries into the clinic: an implementation framework
por: Huang, R Stephanie, et al.
Publicado: (2013)

Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study
por: Armstrong, Nicole D., et al.
Publicado: (2022)

Medication Adherence—Still the Holy Grail
por: Cooper‐DeHoff, Rhonda M., et al.
Publicado: (2023)

Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
por: Pacanowski, Michael A, et al.
Publicado: (2008)

Melatonin Pathway and Atenolol‐Related Glucose Dysregulation: Is There a Correlation?
por: Chang, SW, et al.
Publicado: (2016)

Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients
por: Chekka, Lakshmi Manasa S., et al.
Publicado: (2022)

Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored WISE Study
por: Smith, Steven M., et al.
Publicado: (2014)

Association of Chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression
por: Duarte, Julio D., et al.
Publicado: (2012)

Copy number polymorphisms and anticancer pharmacogenomics
por: Gamazon, Eric R, et al.
Publicado: (2011)

Use of Electronic Health Records to Characterize Patients with Uncontrolled Hypertension in Two Large Health System Networks
por: Lu, Yuan, et al.
Publicado: (2023)

Impact of CYP2C9‐Interacting Drugs on Warfarin Pharmacogenomics
por: Agrawal, Saaket, et al.
Publicado: (2020)

THE IMPACT OF THE COVID-19 PANDEMIC ON A MULTI-CENTER CLINICAL - ADAPTING IN REAL-TIME TO MAINTAIN TRIAL INTEGRITY
por: Dasa, Osama, et al.
Publicado: (2021)

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline‐Based Chemotherapy
por: DeRemer, David L., et al.
Publicado: (2023)

Pathway analysis of genome-wide data improves warfarin dose prediction
por: Daneshjou, Roxana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5hjr8hsn2p8kt6r0gvrmkb6dsu